Fingerprint
Dive into the research topics of 'Final report of KSCC0803: feasibility study of capecitabine as adjuvant chemotherapy for stage III colon cancer in Japan'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Final report of KSCC0803: feasibility study of capecitabine as adjuvant chemotherapy for stage III colon cancer in Japan
KYUSHU STUDY GROUP OF CLINICAL CANCER (KSCC)
Research output: Contribution to journal › Article › peer-review
2
Citations
(Scopus)